XT
CLSD

XTX Topco’s Clearside Biomedical CLSD Stock Holding History

XTX Topco’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,051
Closed -$20K – 2371
2024
Q3 		$20K Sell
1,051
-2,570
-71% -$43.9K ﹤0.01% 1849
2024
Q2 		$70.6K Buy
3,621
+2,291
+172% +$44.3K 0.01% 1468
2024
Q1 		$30.5K Buy
1,330
+52
+4% +$1.12K ﹤0.01% 1551
2023
Q4 		$22.4K Sell
1,278
-558
-30% -$7.96K ﹤0.01% 1348
2023
Q3 		$24K Buy
+1,836
New +$27.8K ﹤0.01% 1355
2022
Q2 		– Sell
-3,396
Closed -$117K – 886
2022
Q1 		$117K Buy
3,396
+1,891
+126% +$56.6K 0.05% 490
2021
Q4 		$62K Buy
+1,505
New +$97.5K 0.04% 537

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

XTX Topco's CLSD Position: Q4 2024 in Review

XTX Topco sold out of Clearside Biomedical (CLSD) in Q4 2024, closing a stake of 1,051 shares — an estimated $20K sold.

XTX Topco first reported a position in CLSD in Q4 2021 and held it in 7 quarters. The position peaked at $117K in Q1 2022. 43 funds tracked by Wall St. Rank hold CLSD as of Q4 2024.

  • XTX Topco reported no remaining Clearside Biomedical position as of Q4 2024 after selling out during the quarter.
  • XTX Topco sold 1,051 Clearside Biomedical shares in Q4 2024, an estimated $20K.
  • XTX Topco first reported a position in Clearside Biomedical in Q4 2021 and held it in 7 quarters.
  • XTX Topco's Clearside Biomedical position peaked at $117K in Q1 2022.
  • 43 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2024.

Based on XTX Topco's 13F filing for Q4 2024, filed 13 Feb 2025.